Efficacy of larotrectinib in pediatric cancers with <i>NTRK</i> gene fusions. [PDF]
Houghton PJ, Bjornsti MA.
europepmc +1 more source
Advancing the treatment of NTRK-fused pediatric solid tumors: lessons from the ADVL1823 study. [PDF]
Vince CSC, Valera ET.
europepmc +1 more source
Current therapeutic landscape and resistance mechanisms to larotrectinib
Weiji Xie +3 more
doaj +1 more source
Clinicopathologic and molecular spectrum of gastrointestinal stromal tumor (GIST) with NTRK fusion and marked response to larotrectinib in GIST with NTRK fusion: a case report. [PDF]
Shen Y +11 more
europepmc +1 more source
TPM3-NTRK1 Fusion Cervical Sarcoma: A Case Report of a Novel Subset of Gynaecological Sarcomas and Successful Treatment of Recurrent Disease With Trk-Inhibition Therapy. [PDF]
Lowe-Zinola J +4 more
europepmc +1 more source
Comprehensive characterization and targeted treatment of a pediatric epithelioid glioblastoma with a rare TRIM24-NTRK2 fusion. [PDF]
Keane S +12 more
europepmc +1 more source
Larotrectinib Demonstrates CNS Efficacy in TRK Fusion-Positive Solid Tumors
Ezra Y. Rosen +8 more
openalex +1 more source
Phase 1/2 study of the selective TRK inhibitor larotrectinib, in pediatric patients with cancer [PDF]
Soledad Gallego +19 more
openalex +1 more source
Neurotrophin NGF/TrkA and BDNF/TrkB signaling orchestrates the immune microenvironment in osteosarcoma. [PDF]
Liu H +6 more
europepmc +1 more source

